Logo

BCCA Purchases RainDance Platform for Cancer Predisposition Gene Sequencing

Nov 17, 2011
Premium

The British Columbia Cancer Agency has purchased RainDance Technologies' ThunderStorm microdroplet PCR platform for use in its Clinical Diagnostic Genomics group, the company said this week.

According to RainDance, over the next two years, BCCA researchers plan to sequence cancer predisposition genes in more than 2,000 samples from patients with a hereditary predisposition to various types of cancer. The researchers want to use that data to guide clinical management.

Filed under

Clinical Sequencing
Sequencing
Diagnostics
BC Cancer Agency
Bio-Rad
Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.